U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07663877) titled 'Remimazolam-Flumazenil Versus Sevoflurane for Hysteroscopic Day Surgery' on June 15.
Brief Summary: This prospective, single-center, randomized controlled trial aims to compare remimazolam anesthesia with planned flumazenil reversal and sevoflurane-based balanced anesthesia in adult women undergoing ambulatory hysteroscopic surgery.
Participants will be randomly assigned in a 1:1 ratio to receive either remimazolam for induction and maintenance followed by flumazenil reversal or propofol induction followed by sevoflurane-based balanced anesthesia. The primary outcome is anesthesia-controlled time, defined as the sum of induction ti...